Nice — below is a concise, source-backed reference for the Laboratory Informatics Market, organized exactly by your headings. I pulled recent market estimates, the commonly-cited vendor list, and available corporate values where public — the most load-bearing facts are cited so you can follow sources.

This versatile research report is presenting crucial details on market relevant information, harping on ample minute details encompassing a multi-dimensional market that collectively maneuver growth in the global Laboratory Informatics market.

Read complete report at: https://www.thebrainyinsights.com/report/laboratory-informatics-market-13698

Quick snapshot (market size & growth — the most important facts)

  • Global market size (2024 estimates): reports cluster around USD ~3.8–5.3 billion for 2024 depending on scope: Grand View Research estimates ~USD 3.86–3.9B (2024); MarketsandMarkets gives a higher series (~USD 5.3B in 2024) because their scope is broader; other providers (Mordor / Precedence) give similar mid-single-digit billion baselines.

  • CAGR / forecast range: commonly reported between ~3%–10% depending on publisher and whether they include cloud/SaaS, services and adjacent segments (examples: Grand View ≈ 5.2% to 2030; MarketsandMarkets ~10.4% to 2029; Mordor reports ~8.3%). Use the lower figure for conservative modeling and the higher if you include cloud/adoption/AI drivers.

Company references — who market reports repeatedly name (with corporate values where publicly disclosed)

Note: market reports commonly list key vendors but rarely disclose “informatics-only” revenue in free summaries. Where firms publish annual results, I list corporate revenue (latest FY) to give scale — these are company totals, not always informatics-only.

  • Thermo Fisher Scientific — repeatedly cited as a top laboratory informatics supplier (across informatics, enterprise lab services, LIMS & ELN integrations). Thermo Fisher corporate revenue (2024): USD 42.88 billion.

  • Danaher (IDBS, Cytiva, etc.) — large life-sciences portfolio that includes informatics capabilities via group businesses. Danaher reported ~USD 23.9–24B revenue (2024).

  • Agilent Technologies — named among top vendors in informatics / lab automation integrations. Agilent revenue (FY2024): ~USD 6.5B.

  • PerkinElmer — active in LIMS, informatics and lab automation solutions. PerkinElmer TTM revenue ≈ USD 3.3B (recent reporting).

  • Waters Corporation — instrument + informatics offerings; Waters revenue (2024): ≈ USD 2.9–3.0B. (Waters also announced a major strategic combination with BD’s diagnostics business in 2025).

  • Other commonly cited vendors (listed across Mordor/Grand View/SkyQuest): LabWare, LabVantage, Abbott (STARLIMS), Agilent, Waters, Autoscribe Informatics, Dotmatics, IDBS (Danaher), LabLynx, Clinisys, Dotmatics, Thermo Fisher (formerly Thermo Scientific informatics lines), Oracle (health/science data), Illumina (analysis software in genomics context). Many of these are named as “key players” in market reports.

Recent developments (last 12–24 months)

  • Cloud & SaaS adoption acceleration: vendors and labs continue migrating LIMS/ELN/SDMS workloads to cloud/SaaS models for scalability, remote collaboration and regulatory traceability.

  • Consolidation & strategic deals: large instrument/solutions companies continue acquiring or partnering with informatics specialists to bundle software + instruments + services. Examples: instrument makers (Thermo Fisher, Danaher, Waters) enhancing software stacks and deal activity across 2023–2025.

  • AI/ML and multi-omics data management push: increasing integration of analytics, bioinformatics and ELN/LIMS to support genomics, proteomics and regulated bio/pharma workflows.

Drivers

  • Growth of life-sciences R&D, diagnostics and precision medicine — more complex data (multi-omics) requires robust informatics platforms.

  • Regulatory pressure & data integrity needs (21 CFR Part 11, GLP/GMP traceability) pushing labs to standardized LIMS/ELN/SDMS solutions.

  • Operational efficiency & lab automation (integration with instruments, sample tracking, automation workflows).

Restraints

  • Fragmented lab IT environments and legacy systems — integration and migration complexity slows sales cycles.

  • High upfront integration and validation costs for regulated labs (especially in pharma and diagnostics).

  • Buyer inertia & long procurement cycles in academic or government labs.

Regional segmentation analysis

  • North America: largest commercial market for high-end informatics (biopharma, CROs, diagnostics) and early cloud adoption.

  • Europe: strong demand from pharma hubs (UK, Germany, Switzerland) and regulated manufacturing; growing cloud adoption tempered by data-localization needs.

  • Asia-Pacific: fastest growth (expanding biopharma, CROs, diagnostics in China, India, South Korea, Japan) — many reports highlight APAC as the growth engine.

  • Rest of world (LATAM, MEA): smaller but rising adoption tied to diagnostics & research upgrades.

Emerging trends

  • Platform consolidation: bundling LIMS + ELN + LES + SDMS into unified platforms or via tighter integrations (market preference for single panes of glass).

  • Low-code/no-code workflow configuration: faster lab workflow configuration without heavy IT involvement.

  • Regulatory automation & AI-assisted QC: automated data-integrity checks and AI tools to speed QC and results review.

Top use cases

  1. Pharmaceutical R&D & regulated QC labs (LIMS, ELN, audit trails).

  2. CROs & contract testing labs (sample management, reporting pipelines).

  3. Clinical diagnostics & pathology labs (middleware/informatics for instruments + LIS/LIMS integration).

  4. Food & beverage, chemical & environmental testing labs (compliance, traceability).

Major challenges

  • Proving ROI for small/mid-sized labs where budgets are tighter.

  • Interoperability & data standards across instruments and vendors.

  • Validation & regulatory compliance workload on customers and vendors for each deployment.

Attractive opportunities

  • SaaS / subscription models & managed services for smaller labs to remove upfront capital barriers.

  • Integrated analytics & AI value-add — monetizable features such as anomaly detection, predictive maintenance and multi-omics pipelines.

  • CRO & biomanufacturing informatics (high recurring revenues; integration with MES / automation).

Key factors of market expansion (summary)

  1. Rising R&D spend & regulated testing needs (pharma, diagnostics).

  2. Cloud/SaaS adoption and standardization of lab workflows.

  3. Vendor consolidation & value-added analytics (AI/ML).

  4. Regional growth in APAC and expansion of CROs & contract testing.

Selected, high-value sources (start here)

  • Grand View Research — market size & segmentation (2024 baseline ~USD 3.86–3.9B; CAGR ~5.2% to 2030).

  • MarketsandMarkets — alternative sizing (broader scope; USD ~5.3B in 2024; CAGR ~10.4% to 2029).

  • Mordor Intelligence — vendor lists and market dynamics (8.3% CAGR example).

  • Precedence Research / GlobeNewswire summaries — complementary sizing and growth figures.

  • Company filings & annual reports (Thermo Fisher, Danaher, Agilent, PerkinElmer, Waters) — corporate revenues & recent corporate moves referenced above.

If you want this packaged into a deliverable, choose one and I’ll build it immediately (I’ll extract company segment/infomatics revenues where available and add source links):

  1. Spreadsheet (Excel/CSV) — top 25 informatics vendors: HQ, corporate revenue (latest FY), whether they offer LIMS/ELN/SDMS/LES, and direct source links.

  2. 1–2 page competitive brief — profiles for the top 8 vendors (Thermo Fisher, Danaher/IDBS, Agilent, LabWare, LabVantage, PerkinElmer, Waters, Autoscribe) including estimated informatics focus and recent deals.

  3. 3-slide PPT — market snapshot, vendor landscape with values, and 3 recommended strategic actions for a lab operator.

Which deliverable (1, 2, or 3) do you want me to produce now?

4K-Smart-OLED-TV.jpg